Nu-Med Plus (NUMD) Assets Average (2013 - 2025)
Nu-Med Plus (NUMD) reported Assets Average of $6479.5 for Q4 2025, down 20.08% on a YoY basis from $8107.0 in Q4 2024, and down 1.91% sequentially from $6605.5 in Q3 2025.
Nu-Med Plus (NUMD) Assets Average (2013 - 2025) Analysis & Trends
Nu-Med Plus (NUMD) has 13 years of Assets Average data on file, last reported at $6479.5 in Q4 2025.
- For the quarter ending Q4 2025, Assets Average fell 20.08% year-over-year to $6479.5; the trailing twelve-month figure through Dec 2025 stood at $6479.5 (down 20.08% YoY), and the FY2025 full-year result was $8642.0, down 24.29% from the prior year.
- Assets Average eased to $6479.5 in Q4 2025, from $6605.5 in the prior quarter.
- In the past five years, Assets Average ranged from a high of $421074.0 in Q1 2021 to a low of $5804.0 in Q3 2022.
- A 5-year average of $50331.0 and a median of $12419.0 in 2023 frame the typical range for Assets Average.
- Across the five-year window, Assets Average jumped 805.55% in 2021 and sank 96.43% in 2022, its largest moves.
- Tracing NUMD's Assets Average over 5 years: stood at $36699.5 in 2021, then increased by 12.69% to $41356.5 in 2022, then sank by 67.11% to $13602.0 in 2023, then plunged by 40.4% to $8107.0 in 2024, then decreased by 20.08% to $6479.5 in 2025.
- Business Quant data shows NUMD's Assets Average at $6479.5 in Q4 2025, $6605.5 in Q3 2025, and $6668.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 98.57 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 47.07 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 92.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.01 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 13.51 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 6.49 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 31.64 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 37.02 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 10.57 Bn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | 6,479.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6,479.50 |
| Sep 30, 2025 | 6,605.50 |
| Jun 30, 2025 | 6,668.00 |
| Mar 31, 2025 | 7,273.00 |
| Dec 31, 2024 | 8,107.00 |
| Sep 30, 2024 | 8,941.00 |
| Jun 30, 2024 | 10,028.50 |
| Mar 31, 2024 | 11,236.00 |
| Dec 31, 2023 | 13,602.00 |
| Sep 30, 2023 | 25,147.50 |
| Jun 30, 2023 | 47,808.00 |
| Mar 31, 2023 | 69,307.00 |
| Dec 31, 2022 | 41,356.50 |
| Sep 30, 2022 | 5,804.00 |
| Jun 30, 2022 | 8,183.00 |
| Mar 31, 2022 | 15,044.50 |
| Dec 31, 2021 | 36,699.50 |
| Sep 30, 2021 | 70,183.00 |
| Jun 30, 2021 | 187,071.50 |
| Mar 31, 2021 | 421,074.00 |